{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T05:09:13Z","timestamp":1755839353621,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-022-03246-w","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T16:07:57Z","timestamp":1657555677000},"page":"129-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Phosphodiesterase1 inhibitor \u201cVinpocetine\u201d ameliorates the inflammation, apoptosis and oxidative stress induced by cyclophosphamide in urinary bladder: an experimental study"],"prefix":"10.1007","volume":"55","author":[{"given":"Rehab Sabri","family":"Abdelrahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-6761","authenticated-orcid":false,"given":"Eman Mohamad El","family":"Nashar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansour Abdullah","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khulood Mohammed","family":"Al-Khater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reham Ismail","family":"Taha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"issue":"1","key":"3246_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/jcp.52.1.75","volume":"52","author":"E Adams","year":"1999","unstructured":"Adams E, Green J, Clark A, Youngson J (1999) Comparison of different scoring systems for immunohistochemical staining. J Clin Pathol 52(1):75\u201377","journal-title":"J Clin Pathol"},{"issue":"1\u20133","key":"3246_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejphar.2013.03.008","volume":"707","author":"C Auge","year":"2013","unstructured":"Auge C, Chene G, Dubourdeau M, Desoubzdanne D, Corman B, Palea S, Lluel P, Vergnolle N, Coelho AM (2013) Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder. Eur J Pharmacol 707(1\u20133):32\u201340","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"3246_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11255-019-02128-y","volume":"51","author":"EN Barut","year":"2019","unstructured":"Barut EN, Engin S, Barut B, Kaya C, Kerimoglu G, Ozel A, Kadioglu M (2019) Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice. Int Urol Nephrol 51(5):803\u2013810","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"3246_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1124\/jpet.112.195446","volume":"343","author":"Y Cai","year":"2012","unstructured":"Cai Y, Knight WE, Guo S, Li JD, Knight PA, Yan C (2012) Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration. J Pharmacol Exp Ther 343(2):479\u2013488","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"3246_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbrc.2013.03.092","volume":"434","author":"Y Cai","year":"2013","unstructured":"Cai Y, Li JD, Yan C (2013) Vinpocetine attenuates lipid accumulation and atherosclerosis formation. Biochem Biophys Res Commun 434(3):439\u2013443","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3246_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.reumae.2014.11.002","volume":"11","author":"JA Cavallasca","year":"2015","unstructured":"Cavallasca JA, Costa CA, MaliandiMdel R, Contini LE, Fernandez de Carrera E, Musuruana JL (2015) Severe infections in patients with autoimmune diseases treated with cyclophosphamide. Reumatol Clin 11(4):221\u2013223. https:\/\/doi.org\/10.1016\/j.reumae.2014.11.002","journal-title":"Reumatol Clin"},{"issue":"8","key":"3246_CR7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1381612805666230110214512","volume":"5","author":"OM Colvin","year":"1999","unstructured":"Colvin OM (1999) An overview of cyclophosphamide development and clinical applications. Curr Pharm Des 5(8):555\u2013560","journal-title":"Curr Pharm Des"},{"issue":"1\u20132","key":"3246_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(01)01175-X","volume":"426","author":"S Cuzzocrea","year":"2001","unstructured":"Cuzzocrea S, Reiter RJ (2001) Pharmacological action of melatonin in shock, inflammation and ischemia\/reperfusion injury. Eur J Pharmacol 426(1\u20132):1\u201310","journal-title":"Eur J Pharmacol"},{"key":"3246_CR9","volume":"144","author":"D Dan","year":"2014","unstructured":"Dan D, Fischer R, Adler S, F\u00f6rger F, Villiger PM (2014) Cyclophosphamide: as bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases. Swiss Med Wkly 144:w14030","journal-title":"Swiss Med Wkly"},{"key":"3246_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1146\/annurev.pharmtox.41.1.691","volume":"41","author":"WC De Groat","year":"2001","unstructured":"De Groat WC, Yoshimura N (2001) Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol 41:691\u2013721. https:\/\/doi.org\/10.1146\/annurev.pharmtox.41.1.691","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"3246_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1464-410X.2007.07011.x","volume":"100","author":"R De Jongh","year":"2007","unstructured":"De Jongh R, van Koeveringe GA, van Kerrebroeck PE, MarkerinkvanIttersum M, de Vente J, Gillespie JI (2007) The effects of exogenous prostaglandins and the identification of constitutive cyclooxygenase I and II immunoreactivity in the normal guinea pig bladder. BJU Int 100(2):419\u2013429. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.07011.x","journal-title":"BJU Int"},{"issue":"2","key":"3246_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/0960327120947453","volume":"40","author":"AA Elnfarawy","year":"2020","unstructured":"Elnfarawy AA, Nashy AE, Abozaid AM, Komber IF, Elweshahy RH, Abdelrahman RS (2020) Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats. Hum Exp Toxicol 40(2):355\u2013368","journal-title":"Hum Exp Toxicol"},{"issue":"11","key":"3246_CR13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"A Emadi","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA (2009) Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 6(11):638\u2013647","journal-title":"Nat Rev Clin Oncol"},{"key":"3246_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phrs.2016.12.039","volume":"120","author":"V Fattori","year":"2017","unstructured":"Fattori V, Borghi SM, Guazelli CFS, Giroldo AC, Crespigio J, Bussmann AJC, Coelho-Silva L, Ludwig NG, Mazzuco TL, Casagrande R, Verri WA Jr (2017) Vinpocetine reduces diclofenac-induced acute kidney injury through inhibition of oxidative stress, apoptosis, cytokine production, and NF-\u03baB activation in mice. Pharmacol Res 120:10\u201322","journal-title":"Pharmacol Res"},{"issue":"8","key":"3246_CR15","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1177\/27.8.90074","volume":"27","author":"J-L Guesdon","year":"1979","unstructured":"Guesdon J-L, Ternynck T, Avrameas S (1979) The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27(8):1131\u20131139","journal-title":"J Histochem Cytochem"},{"issue":"10","key":"3246_CR16","doi-asserted-by":"publisher","first-page":"e22555","DOI":"10.1002\/jbt.22555","volume":"34","author":"SA Habib","year":"2020","unstructured":"Habib SA, Abdelrahman RS, Abdel Rahim M, Suddek GM (2020) Anti-apoptotic effect of vinpocetine on cisplatin-induced hepatotoxicity in mice: the role of Annexin-V, Caspase-3, and Bax. J Biochem Mol Toxicol 34(10):e22555","journal-title":"J Biochem Mol Toxicol"},{"key":"3246_CR17","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Pharmaceuticals. Lyon (FR): International Agency for Research on Cancer; 2012. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100A.) CYCLOPHOSPHAMIDE. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK304336\/"},{"issue":"21","key":"3246_CR18","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1073\/pnas.0914414107","volume":"107","author":"KI Jeon","year":"2010","unstructured":"Jeon KI, Xu X, Aizawa T, Lim JH, Jono H, Kwon DS, Abe J, Berk BC, Li JD, Yan C (2010) Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proc Natl Acad Sci U S A 107(21):9795\u20139800","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"3246_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S1065-6995(03)00175-6","volume":"27","author":"K Jezernik","year":"2003","unstructured":"Jezernik K, Romih R, Mannherz HG, Koprivec D (2003) Immunohistochemical detection of apoptosis, proliferation and inducible nitric oxide synthase in rat urothelium damaged by cyclophosphamide treatment. Cell Biol Int 27(10):863\u2013869","journal-title":"Cell Biol Int"},{"key":"3246_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.fct.2013.11.023","volume":"64","author":"SH Kim","year":"2014","unstructured":"Kim SH, Lee IC, Baek HS, Shin IS, Moon C, Bae CS, Kim SH, Kim JC, Kim HC (2014) Mechanism for the protective effect of diallyl disulfide against cyclophosphamide acute urotoxicity in rats. Food Chem Toxicol 64:110\u2013118. https:\/\/doi.org\/10.1016\/j.fct.2013.11.023 (Epub 2013 Nov 27 PMID: 24291451)","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"3246_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/jcp.54.5.356","volume":"54","author":"D Koracevic","year":"2001","unstructured":"Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V (2001) Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 54(5):356\u2013361","journal-title":"J Clin Pathol"},{"issue":"5","key":"3246_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","volume":"23","author":"A Korkmaz","year":"2007","unstructured":"Korkmaz A, Topal T, Oter S (2007) Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 23(5):303\u2013312","journal-title":"Cell Biol Toxicol"},{"issue":"6","key":"3246_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","volume":"59","author":"V Lakics","year":"2010","unstructured":"Lakics V, Karran EH, Boess FG (2010) Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology 59(6):367\u2013374","journal-title":"Neuropharmacology"},{"key":"3246_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","volume":"109","author":"C Lugnier","year":"2006","unstructured":"Lugnier C (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109:366\u2013398","journal-title":"Pharmacol Ther"},{"issue":"22","key":"3246_CR25","doi-asserted-by":"publisher","first-page":"9921","DOI":"10.1073\/pnas.1005138107","volume":"107","author":"AE Medina","year":"2010","unstructured":"Medina AE (2010) Vinpocetine as a potent antiinflammatory agent. Proc Natl Acad Sci USA 107(22):9921\u20139922","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"3246_CR26","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1007\/s00204-019-02589-1","volume":"93","author":"KA Mills","year":"2019","unstructured":"Mills KA, Chess-Williams R, McDermott C (2019) Novel insights into the mechanism of cyclophosphamide-induced bladder toxicity: chloroacetaldehyde\u2019s contribution to urothelial dysfunction in vitro. Arch Toxicol 93(11):3291\u20133303","journal-title":"Arch Toxicol"},{"issue":"1","key":"3246_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/35.1.3025290","volume":"35","author":"DJ Morley","year":"1987","unstructured":"Morley DJ, Hawley DM, Ulbright TM, Butler LG, Culp JS, Hodes ME (1987) Distribution of phosphodiesterase I in normal human tissues. J Histochem Cytochem 35(1):75\u201382","journal-title":"J Histochem Cytochem"},{"key":"3246_CR28","volume-title":"Cyclophosphamide","author":"MH Ogino","year":"2021","unstructured":"Ogino MH, Tadi P (2021) Cyclophosphamide. Treasure Island (FL), StatPearls Publishing, StatPearls"},{"issue":"6","key":"3246_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/002215549904700603","volume":"47","author":"K Persson","year":"1999","unstructured":"Persson K, Poljakovic M, Johansson K, Larsson B (1999) Morphological and biochemical investigation of nitric oxide synthase and related enzymes in the rat and pig urothelium. J Histochem Cytochem 47(6):739\u2013749","journal-title":"J Histochem Cytochem"},{"issue":"6","key":"3246_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s00240-001-0221-6","volume":"29","author":"Y Qiu","year":"2001","unstructured":"Qiu Y, Kraft P, Craig EC, Liu X, Haynes-Johnson D (2001) Identification and functional study of phosphodiesterases in rat urinary bladder. Urol Res 29(6):388\u2013392","journal-title":"Urol Res"},{"issue":"1","key":"3246_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0090-4295(01)01471-6","volume":"59","author":"Y Qiu","year":"2002","unstructured":"Qiu Y, Kraft P, Craig EC, Liu X, Haynes-Johnson D (2002) Cyclic nucleotide phosphodiesterases in rabbit detrusor smooth muscle. Urology 59(1):145\u2013149","journal-title":"Urology"},{"issue":"12","key":"3246_CR32","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1073\/pnas.0307446101","volume":"101","author":"R Radi","year":"2004","unstructured":"Radi R (2004) Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 101(12):4003\u20134008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3246_CR33","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0891-5849(02)01111-5","volume":"33","author":"R Radi","year":"2002","unstructured":"Radi R, Cassina A, Hodara R, Quijano C, Castro L (2002) Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 33(11):1451\u20131464","journal-title":"Free Radic Biol Med"},{"key":"3246_CR34","doi-asserted-by":"publisher","DOI":"10.26481\/dis.20131122mr","author":"MS Rahnama\u2019i","year":"2013","unstructured":"Rahnama\u2019i MS (2013) Prostaglandins and phosphodiesterases in the urinary bladder wall. Maastricht Univ. https:\/\/doi.org\/10.26481\/dis.20131122mr","journal-title":"Maastricht Univ"},{"issue":"3","key":"3246_CR35","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.juro.2009.11.004","volume":"183","author":"MS Rahnama'i","year":"2010","unstructured":"Rahnama\u2019i MS, van Koeveringe GA, Essers PB, de Wachter SG, de Vente J, van Kerrebroeck PE et al (2010) Prostaglandin receptor EP1 and EP2 site in guinea pig bladder urothelium and lamina propria. J Urol 183(3):1241\u20131247","journal-title":"J Urol"},{"issue":"7","key":"3246_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrurol.2013.101","volume":"10","author":"MS Rahnama'i","year":"2013","unstructured":"Rahnama\u2019i MS, Uckert S, Hohnen R, van Koeveringe GA (2013) The role of phosphodiesterases in bladder pathophysiology. Nat Rev Urol 10(7):414\u2013424","journal-title":"Nat Rev Urol"},{"issue":"2","key":"3246_CR37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/bju.12031","volume":"112","author":"MS Rahnama'i","year":"2013","unstructured":"Rahnama\u2019i MS, van Koeveringe GA, Hohnen R, Ona S, van Kerrebroeck PE, de Wachter SG (2013) Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder. BJU Int 112(2):246\u2013257","journal-title":"BJU Int"},{"issue":"10","key":"3246_CR38","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00345-014-1455-6","volume":"33","author":"MS Rahnama\u2019i","year":"2015","unstructured":"Rahnama\u2019i MS, Hohnen R, van Kerrebroeck PE, van Koeveringe GA (2015) Phosphodiesterase type 2 distribution in the guinea pig urinary bladder. World J Urol 33(10):1623\u20131633","journal-title":"World J Urol"},{"issue":"5","key":"3246_CR39","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1016\/S0022-5347(05)65134-8","volume":"167","author":"RA Ribeiro","year":"2002","unstructured":"Ribeiro RA, Freitas HC, Campos MC, Santos CC, Figueiredo FC, Brito GA, Cunha FQ (2002) Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol 167(5):2229\u20132234","journal-title":"J Urol"},{"issue":"3","key":"3246_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118942","volume":"10","author":"KW Ruiz-Miyazawa","year":"2015","unstructured":"Ruiz-Miyazawa KW, Zarpelon AC, Pinho-Ribeiro FA, Pavao-de-Souza GF, Casagrande R, Verri WA Jr (2015) Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-kappaB activation in the paw and spinal cord. PLoS ONE 10(3):e0118942","journal-title":"PLoS ONE"},{"issue":"5","key":"3246_CR41","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cbf.1347","volume":"25","author":"S Sadir","year":"2007","unstructured":"Sadir S, Deveci S, Korkmaz A, Oter S (2007) Alpha-tocopherol, beta-carotene and melatonin administration protects cyclophosphamide-induced oxidative damage to bladder tissue in rats. Cell Biochem Funct 25(5):521\u2013526","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"3246_CR42","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1152\/japplphysiol.00987.2016","volume":"122","author":"J Schipke","year":"1985","unstructured":"Schipke J, Brandenberger C, Rajces A et al (1985) 2017 Assessment of cardiac fibrosis: a morphometric method comparison for collagen quantification. J Appl Physiol 122(4):1019\u20131030","journal-title":"J Appl Physiol"},{"key":"3246_CR43","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00210-018-1510-8","volume":"391","author":"D Sellers","year":"2018","unstructured":"Sellers D, Chess-Williams R, Michel MC (2018) Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 391:675\u2013694. https:\/\/doi.org\/10.1007\/s00210-018-1510-8","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"2","key":"3246_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/10520295.2016.1259499","volume":"92","author":"MF S\u00f6nmez","year":"2017","unstructured":"S\u00f6nmez MF, Ozdemir \u015e, Guzel M, Kaymak E (2017) The ameliorative effects of vinpocetine on apoptosis and HSP-70 expression in testicular torsion in rats. Biotech Histochem 92(2):92\u201399","journal-title":"Biotech Histochem"},{"issue":"4","key":"3246_CR45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1600-079X.2004.00202.x","volume":"38","author":"T Topal","year":"2005","unstructured":"Topal T, Oztas Y, Korkmaz A, Sadir S, Oter S, Coskun O, Bilgic H (2005) Melatonin ameliorates bladder damage induced by cyclophosphamide in rats. J Pineal Res 38(4):272\u2013277","journal-title":"J Pineal Res"},{"issue":"7","key":"3246_CR46","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s00120-009-1970-z","volume":"48","author":"S Uckert","year":"2009","unstructured":"Uckert S, Sigl K, Waldkirch ES, Sandner P, Ulbrich E, Oelke M, Stief CG, Kuczyk MA (2009) Significance of phosphodiesterase isoenzymes in the control of human detrusor smooth muscle function. An immunohistochemical and functional study. Urologe A 48(7):764\u2013769","journal-title":"Urologe A"},{"issue":"1\u20132","key":"3246_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11010-006-9352-y","volume":"298","author":"SD Varma","year":"2007","unstructured":"Varma SD, Hegde KR (2007) Lens thiol depletion by peroxynitrite. Protective effect of pyruvate. Mol Cell Biochem 298(1\u20132):199\u2013204","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"3246_CR48","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neulet.2007.05.043","volume":"421","author":"C Wantuch","year":"2007","unstructured":"Wantuch C, Piesla M, Leventhal L (2007) Pharmacological validation of a model of cystitis pain in the mouse. Neurosci Lett 421(3):250\u2013252","journal-title":"Neurosci Lett"},{"issue":"1","key":"3246_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/157488506775268515","volume":"1","author":"J Zhang","year":"2006","unstructured":"Zhang J, Tian Q, Zhou S-F (2006) Clinical pharmacology of cyclophosphamide and ifosfamide. Current Drug Therapy 1(1):55\u201384","journal-title":"Current Drug Therapy"},{"key":"3246_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejphar.2017.11.041","volume":"819","author":"YS Zhang","year":"2018","unstructured":"Zhang YS, Li JD, Yan C (2018) An update on vinpocetine: new discoveries and clinical implications. Eur J Pharmacol 819:30\u201334","journal-title":"Eur J Pharmacol"},{"issue":"2\u20134","key":"3246_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1017\/S1740925X12000129","volume":"7","author":"YY Zhao","year":"2011","unstructured":"Zhao YY, Yu JZ, Li QY, Ma CG, Lu CZ, Xiao BG (2011) TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation. Neuron Glia Biol 7(2\u20134):187\u2013197","journal-title":"Neuron Glia Biol"},{"issue":"12","key":"3246_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082509","volume":"8","author":"J Zhuang","year":"2013","unstructured":"Zhuang J, Peng W, Li H, Lu Y, Wang K, Fan F, Li S, Xu Y (2013) Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt\/NF-\u03baB dependent mechanisms in apoE-\/- mice. PLoS ONE 8(12):e82509","journal-title":"PLoS ONE"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03246-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-022-03246-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03246-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T09:18:32Z","timestamp":1676107112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-022-03246-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["3246"],"URL":"https:\/\/doi.org\/10.1007\/s11255-022-03246-w","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2022,7,11]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}